RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      COVID-19 소아 환자의 임상 양상 및 실험실적 특징: 체계적문헌고찰 및 메타분석

      한글로보기

      https://www.riss.kr/link?id=A107184059

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: Although the identification of clinical and laboratory features in pediatric COVID-19 patients is essential in establishing an appropriate treatment plan, a systematic review and meta-analysis on the topic has yet to be reported. Methods: We searched MEDLINE, Embase, and Web of Science to access clinical and laboratory characteristics as well as clinical outcomes of children with COVID-19 infection. A meta-analysis using random-effect model was performed to estimate pooled prevalence and 95% confidence intervals. Results: Among the 532 studies initially collected, 12 articles were finally included in the meta-analysis. Among the investigated 320 pediatric patients with COVID-19, fever (48.2%) and cough (39.3%) were the most common symptoms. Almost one third of patients (30.4%) were asymptomatic. In laboratory findings, only 11.4% of pediatric patients experienced lymphocytopenia. Increased inflammatory markers including c-reactive protein (18.6%) and procalcitonin (32.4%) were observed. Only a few patients needed mechanical ventilation and intensive care support, and only one death was reported. Conclusion: Pediatric patients with COVID-19 infection exhibited milder symptoms and more favorable outcomes compared to adults. However, considering the high rate of asymptomatic pediatric patients, close monitoring is required to prevent community infection in asymptomatic conditions and hidden disease progression.
      번역하기

      Background: Although the identification of clinical and laboratory features in pediatric COVID-19 patients is essential in establishing an appropriate treatment plan, a systematic review and meta-analysis on the topic has yet to be reported. Methods: ...

      Background: Although the identification of clinical and laboratory features in pediatric COVID-19 patients is essential in establishing an appropriate treatment plan, a systematic review and meta-analysis on the topic has yet to be reported. Methods: We searched MEDLINE, Embase, and Web of Science to access clinical and laboratory characteristics as well as clinical outcomes of children with COVID-19 infection. A meta-analysis using random-effect model was performed to estimate pooled prevalence and 95% confidence intervals. Results: Among the 532 studies initially collected, 12 articles were finally included in the meta-analysis. Among the investigated 320 pediatric patients with COVID-19, fever (48.2%) and cough (39.3%) were the most common symptoms. Almost one third of patients (30.4%) were asymptomatic. In laboratory findings, only 11.4% of pediatric patients experienced lymphocytopenia. Increased inflammatory markers including c-reactive protein (18.6%) and procalcitonin (32.4%) were observed. Only a few patients needed mechanical ventilation and intensive care support, and only one death was reported. Conclusion: Pediatric patients with COVID-19 infection exhibited milder symptoms and more favorable outcomes compared to adults. However, considering the high rate of asymptomatic pediatric patients, close monitoring is required to prevent community infection in asymptomatic conditions and hidden disease progression.

      더보기

      목차 (Table of Contents)

      • ABSTRACT
      • Methods
      • Search Strategy
      • Inclusion and Exclusion Criteria
      • Data extraction and Quality assessment
      • ABSTRACT
      • Methods
      • Search Strategy
      • Inclusion and Exclusion Criteria
      • Data extraction and Quality assessment
      • Statistical analysis
      • Results
      • Identification and characteristics of the included studies
      • Quantitative data synthesis
      • Discussion
      • Conclusion
      • Conflict of Interest
      • References
      더보기

      참고문헌 (Reference)

      1 The World Health Organization, "Weekly operational update on COVID-19-7 December 2020"

      2 Rothe C, "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany" 382 (382): 970-971, 2020

      3 Su L, "The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19" 9 (9): 707-713, 2020

      4 Safadi M, "The challenging and unpredictable spectrum of COVID-19 in children and adolescents" 39 : e2020192-, 2020

      5 Lu X, "SARS-CoV-2 Infection in Children" 382 (382): 1663-1665, 2020

      6 Tregoning JS, "Respiratory viral infections in infants:causes, clinical symptoms, virology, and immunology" 23 (23): 74-98, 2010

      7 The National Health Commision of the People’s Republic of China, "Protocol on prevention and control of COVID-19 (Edition 6)"

      8 Wei M, "Novel coronavirus infection in hospitalized infants under 1 year of age in China" 323 (323): 1313-1314, 2020

      9 Joanna Briggs Institute, "JBI manual for evidence synthesis"

      10 Liu M, "High-resolution computed tomography manifestations of 5 pediatric patients With 2019 novel Coronavirus" 44 (44): 311-313, 2020

      1 The World Health Organization, "Weekly operational update on COVID-19-7 December 2020"

      2 Rothe C, "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany" 382 (382): 970-971, 2020

      3 Su L, "The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19" 9 (9): 707-713, 2020

      4 Safadi M, "The challenging and unpredictable spectrum of COVID-19 in children and adolescents" 39 : e2020192-, 2020

      5 Lu X, "SARS-CoV-2 Infection in Children" 382 (382): 1663-1665, 2020

      6 Tregoning JS, "Respiratory viral infections in infants:causes, clinical symptoms, virology, and immunology" 23 (23): 74-98, 2010

      7 The National Health Commision of the People’s Republic of China, "Protocol on prevention and control of COVID-19 (Edition 6)"

      8 Wei M, "Novel coronavirus infection in hospitalized infants under 1 year of age in China" 323 (323): 1313-1314, 2020

      9 Joanna Briggs Institute, "JBI manual for evidence synthesis"

      10 Liu M, "High-resolution computed tomography manifestations of 5 pediatric patients With 2019 novel Coronavirus" 44 (44): 311-313, 2020

      11 The World Health Oraganization, "Global surveillance for human infection with novel coronavirus (2019-ncov): interim guidance"

      12 Wan X, "Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range" 14 : 135-, 2014

      13 Mizumoto K, "Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19)cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020" 25 (25): 2000180-, 2020

      14 Assiri A, "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study" 13 (13): 752-761, 2013

      15 Dong Y, "Epidemiological characteristics of 2143pediatric patients with 2019 Coronavirus disease in China" 58 (58): 712-713, 2020

      16 Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study" 395 (395): 507-513, 2020

      17 Liu W, "Detection of Covid-19 in children in early January 2020 in Wuhan, China" 382 (382): 1370-1371, 2020

      18 Rodriguez-Morales AJ, "Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis" 34 : 101623-, 2020

      19 The World Health Oraganization, "Clinical management of severe acute respiratory infection(SARI)when COVID-19 disease is suspected" 21 (21): 734-, 2020

      20 Zhou Y, "Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children" 22 (22): 215-220, 2020

      21 Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study" 395 (395): 1054-1062, 2020

      22 Sun P, "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection : A single arm meta-analysis" 92 (92): 612-617, 2020

      23 Zheng F, "Clinical characteristics of children with coronavirus disease 2019 in Hubei, China" 40 (40): 275-280, 2020

      24 Du W, "Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China" 48 (48): 445-452, 2020

      25 Qiu H, "Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study" 20 (20): 689-696, 2020

      26 Liu H, "Clinical and CT imaging features of the COVID-19 pneumonia : Focus on pregnant women and children" 80 (80): e7-e13, 2020

      27 Wang D, "Clinical analysis of 31 cases of 2019novel coronavirus infection in children from six provinces (autonomous region) of northern China" 58 (58): 269-274, 2020

      28 Campbell H, "Child pneumonia at a time of epidemiological transition" 3 (3): e65-e66, 2015

      29 Li W, "Chest computed tomography in children with COVID-19 respiratory infection" 50 (50): 796-799, 2020

      30 Kelvin AA, "COVID-19 in children : the link in the transmission chain" 20 (20): 633-634, 2020

      31 Al-Tawfiq JA, "Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)" 35 : 101608-, 2020

      32 Chan JF, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission : a study of a family cluster" 395 (395): 514-523, 2020

      33 Tsang KW, "A cluster of cases of severe acute respiratory syndrome in Hong Kong" 348 (348): 1977-1985, 2003

      34 Jiehao C, "A Case Series of children with 2019 novel coronavirus infection : clinical and epidemiological features" 71 (71): 1547-1551, 2020

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-05-10 학술지등록 한글명 : 한국임상약학회지
      외국어명 : Korean Journal of Clinical Pharmacy
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.17
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.15 0.432 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼